Kymera Therapeutics, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
KYMR
Kymera Therapeutics, Inc. Common Stock
$119.80 -1.40%
VS TWSTTwist Bioscience Corporation Common Stock
$145.59 +6.79%
Twist Bioscience Corporation Common Stock (TWST) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| KYMR | TWST | |
|---|---|---|
| Market Cap | $10.59 billion | $8.55 billion |
| Revenue (TTM) | $105.00 million | $431.80 million |
| Net Income (TTM) | $-299,601,000 | $-136,717,000 |
TWST leads on 2 of 3 size & scale factors.
Valuation
| KYMR | TWST | |
|---|---|---|
| Price / Book | 7.01 | 19.18 |
| Price / Sales | 100.82 | 19.80 |
KYMR and TWST split the valuation factors evenly.
Profitability
| KYMR | TWST | |
|---|---|---|
| Net Margin | -285.34% | -31.66% |
| Return on Equity | -19.85% | -30.67% |
KYMR and TWST split the profitability factors evenly.
Risk & Sentiment
| KYMR | TWST | |
|---|---|---|
| Short Interest | 0.24% | 0.08% |
TWST leads on 1 of 1 risk & sentiment factors.
Dig deeper: KYMR overview, KYMR financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.